Prophylactic central neck dissection in stage N0 papillary thyroid carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 11, 2009, Pages 1087-1091

  Zuniga, Sergio ^a   Sanabria, Alvaro ^b  

^a Clinica Las Americas   (Colombia)

^b UNIVERSIDAD DE LA SABANA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NECK DISSECTION; PREOPERATIVE EVALUATION; PROPORTIONAL HAZARDS MODEL; THYROID PAPILLARY CARCINOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; COLOMBIA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SURVIVAL RATE; THYROID NEOPLASMS; TIME FACTORS; YOUNG ADULT;

EID: 73249128367     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2009.163     Document Type: Article

References (29)

1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164-2167.
2. Williams ED. Chernobyl and thyroid cancer. J Surg Oncol. 2006;94(8):670-677.
3. Cooper DS, Doherty GM, Haugen BR, et al; American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16(2):109-142.
4. Lee SH, Lee SS, Jin SM, Kim JH, Rho YS. Predictive factors for central compartment lymph node metastasis in thyroid papillary microcarcinoma. Laryngoscope. 2008;118(4):659-662.
5. Davidson HC, Park BJ, Johnson JT. Papillary thyroid cancer: controversies in the management of neck metastasis. Laryngoscope. 2008;118(12):2161- 2165.
6. Shindo M, Wu JC, Park EE, Tanzella F. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg. 2006;132(6):650-654.
7. Al-Balawi IA, Meir HM, Yousef MK, Nayel HA, Al-Mobarak MF. Differentiated thyroid carcinoma referred for radioiodine therapy. Saudi Med J. 2001;22(6):497-503.
8. Wiseman SM, Hicks WL Jr, Chu QD, Rigual NR. Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review. Surg Oncol. 2002; 11(3):137-142.
9. Ito Y, Miyauchi A. Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg. 2007; 31(5):905-915.
10. Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg. 2007;245(4):604-610.
11. Lachin JM, Foulkes MA. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics. 1986;42(3):507-519.
12. Cady B, Rossi R. En expanded view of risk group definition in differentiated thyroid carcinoma. Surgery. 1988;104(6):947-953.
13. Grodski S, Cornford L, Sywak M, Sidhu S, Delbridge L. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique. ANZ J Surg. 2007; 77(4):203-208.
14. Noguchi M, Kumaki T, Taniya T, et al. A retrospective study on the efficacy of cervical lymph node dissection in well-differentiated carcinoma of the thyroid. Jpn J Surg. 1990;20(2):143-150.
15. White ML, Doherty GM. Level VI lymph node dissection for papillary thyroid cancer. Minerva Chir. 2007;62(5):383-393.
16. Machens A, Holzhausen HJ, Dralle H. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg. 2004;139(1):43-45.
17. Roh JL, Park JY, Rha KS, Park CI. Is central neck dissection necessary for the treatment of lateral cervical nodal recurrence of papillary thyroid carcinoma? Head Neck. 2007;29(10):901-906.
18. Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237(3):399-407.
19. Pereira JA, Jimeno J, Miquel J, et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery. 2005;138 (6):1095-1101.
20. Coburn MC, Wanebo HJ. Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg. 1992;164(6): 671-676.
21. Palme CE, Waseem Z, Raza SN, Eski S, Walfish P, Freeman JL. Management and outcome of recurrent well-differentiated thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130(7):819-824.
22. Jacquot-Laperrière S, Timoshenko AP, Dumollard JM, et al. Papillary thyroid microcarcinoma: incidence and prognostic factors. Eur Arch Otorhinolaryngol. 2007; 264(8):935-939.
23. Roh JL, Kim JM, Park CI. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Ann Surg Oncol. 2008;15(9):2482-2486.
24. Shaha AR, Shah JP, Loree TR. Low-risk differentiated thyroid cancer: the need for selective treatment. Ann Surg Oncol. 1997;4(4):328-333.
25. Sanders LE, Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg. 1998;133(4):419-425.
26. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312(25):1604-1608.
27. Pacini F, Schlumberger M, Harmer C, et al. Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. Eur J Endocrinol. 2005;153(5):651-659.
28. Palestini N, Borasi A, Cestino L, Freddi M, Odasso C, Robecchi A. Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? our experience. Langenbecks Arch Surg. 2008;393(5):693-698.
29. National Comprehensive Cancer Center. Clinical practice guidelines in oncology. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed June 30, 2009.